Consequences of the recurrent MYD88L265P somatic mutation for B cell tolerance

Journal of Experimental Medicine

Volumn 211, Issue 3, 2014, Pages 413-426

  Wang, James Q ^a   Jeelall, Yogesh S ^a   Beutler, Bruce ^b   Horikawa, Keisuke ^a   Goodnow, Christopher C ^a  

^a Biology and Environment   (Australia)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIM PROTEIN; CHLOROQUINE; DNA; I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIGAND; MYELOID DIFFERENTIATION FACTOR 88; NUCLEIC ACID; PROTEIN BCL 2; RNA; TOLL LIKE RECEPTOR 9;

ALLELE; ANIMAL CELL; APOPTOSIS; ARTICLE; B LYMPHOCYTE; CELL DIVISION; CELL PROLIFERATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; GENE TRANSFER; IN VITRO STUDY; INDUCED MUTATION; LARGE CELL LYMPHOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SOMATIC MUTATION; VIRAL GENE DELIVERY SYSTEM; WALDENSTROEM MACROGLOBULINEMIA;

ADOPTIVE TRANSFER; ANIMALS; APOPTOSIS; B-LYMPHOCYTES; BLOTTING, WESTERN; CELL DIVISION; CELL PROLIFERATION; CYSTEINE ENDOPEPTIDASES; GENE EXPRESSION REGULATION; GENE REARRANGEMENT, B-LYMPHOCYTE; IMMUNE TOLERANCE; IMMUNOPROLIFERATIVE DISORDERS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MUTATION, MISSENSE; MYELOID DIFFERENTIATION FACTOR 88; NF-KAPPA B; PROMOTER REGIONS, GENETIC; PROTO-ONCOGENE PROTEINS C-BCL-2; PROTO-ONCOGENE PROTEINS C-VAV;

EID: 84896814479     PISSN: 00221007     EISSN: 15409538     Source Type: Journal    
DOI: 10.1084/jem.20131424     Document Type: Article

References (52)

1. Akira, S., and K. Takeda. 2004. Toll-like receptor signalling. Nat. Rev. Immunol. 4:499-511. http://dx.doi.org/10.1038/nri1391
2. ar-Rushdi, A., K. Nishikura, J. Erikson, R. Watt, G. Rovera, and C.M. Croce. 1983. Differential expression of the translocated and the untranslocated c-myc oncogene in Burkitt lymphoma. Science. 222:390-393.
3. Balkwill, F., and A. Mantovani. 2001. Inflammation and cancer: back to Virchow? Lancet. 357:539-545. http://dx.doi.org/10.1016/S0140-6736(00)04046-0 Beutler, B. 2004. Toll-like receptors and their place in immunology. Where does the immune response to infection begin? Nat. Rev. Immunol. 4:498. http://dx.doi.org/10.1038/nri1401
4. Beutler, B. 2004. Toll-like receptors and their place in immunology. Where does the immune response to infection begin? Nat. Rev. Immunol. 4:498. http://dx.doi.org/10.1038/nri1401
5. Bouillet, P., D. Metcalf, D.C. Huang, D.M. Tarlinton, T.W. Kay, F. Köntgen, J.M. Adams, and A. Strasser. 1999. Proapoptotic Bcl-2 relative Bim required for certain apoptotic responses, leukocyte homeostasis, and to preclude autoimmunity. Science. 286:1735-1738. http://dx.doi.org/10.1126/science.286.5445.1735
6. Braggio, E., J.J. Keats, X. Leleu, S. Van Wier, V.H. Jimenez-Zepeda, R. Valdez, R.F. Schop, T. Price-Troska, K. Henderson, A. Sacco, et al. 2009. Identification of copy number abnormalities and inactivating mutations in two negative regulators of nuclear factor-kappaB signaling pathways in Waldenstrom's macroglobulinemia. Cancer Res. 69:3579-3588. http://dx.doi.org/10.1158/0008-5472.CAN-08-3701
7. Choi, J.W., Y. Kim, J.H. Lee, and Y.S. Kim. 2013. MYD88 expression and L265P mutation in diffuse large B-cell lymphoma. Hum. Pathol. 44:1375- 1381. http://dx.doi.org/10.1016/j.humpath.2012.10.026
8. Coornaert, B., M. Baens, K. Heyninck, T. Bekaert, M. Haegman, J. Staal, L. Sun, Z.J. Chen, P. Marynen, and R. Beyaert. 2008. T cell antigen receptor stimulation induces MALT1 paracaspase-mediated cleavage of the NF-kappaB inhibitor A20. Nat. Immunol. 9:263-271. http://dx.doi.org/10.1038/ni1561
9. Cory, S. 1995. Regulation of lymphocyte survival by the bcl-2 gene family. Annu. Rev. Immunol. 13:513-543. http://dx.doi.org/10.1146/annurev.iy.13.040195.002501
10. Cyster, J.G., S.B. Hartley, and C.C. Goodnow. 1994. Competition for follicular niches excludes self-reactive cells from the recirculating B-cell repertoire. Nature. 371:389-395. http://dx.doi.org/10.1038/371389a0
11. Deane, J.A., P. Pisitkun, R.S. Barrett, L. Feigenbaum, T. Town, J.M. Ward, R.A. Flavell, and S. Bolland. 2007. Control of toll-like receptor 7 expression is essential to restrict autoimmunity and dendritic cell proliferation. Immunity. 27:801-810. http://dx.doi.org/10.1016/j.immuni.2007.09.009
12. Egle, A., A.W. Harris, M.L. Bath, L. O'Reilly, and S. Cory. 2004. VavP-Bcl2 transgenic mice develop follicular lymphoma preceded by germinal center hyperplasia. Blood. 103:2276-2283. http://dx.doi.org/10.1182/blood-2003-07-2469
13. Ewald, S.E., B.L. Lee, L. Lau, K.E. Wickliffe, G.P. Shi, H.A. Chapman, and G.M. Barton. 2008. The ectodomain of Toll-like receptor 9 is cleaved to generate a functional receptor. Nature. 456:658-662. http://dx.doi.org/10.1038/nature07405
14. Goodnow, C.C. 2007. Multistep pathogenesis of autoimmune disease. Cell. 130:25-35. http://dx.doi.org/10.1016/j.cell.2007.06.033
15. Goodnow, C.C., and P. Ohashi. 2013. Immunological tolerance. In Fundamental Immunology, W.E. Paul, ed. Philadelphia: Lippincott Williams & Wilkins.
16. Goodnow, C.C., J. Crosbie, S. Adelstein, T.B. Lavoie, S.J. Smith-Gill, R.A. Brink, H. Pritchard-Briscoe, J.S. Wotherspoon, R.H. Loblay, K. Raphael, et al. 1988. Altered immunoglobulin expression and functional silencing of self-reactive B lymphocytes in transgenic mice. Nature. 334:676-682. http://dx.doi.org/10.1038/334676a0
17. Graham, R.R., C. Cotsapas, L. Davies, R. Hackett, C.J. Lessard, J.M. Leon, N.P. Burtt, C. Guiducci, M. Parkin, C. Gates, et al. 2008. Genetic variants near TNFAIP3 on 6q23 are associated with systemic lupus erythematosus. Nat. Genet. 40:1059-1061. http://dx.doi.org/10.1038/ng.200
18. Harhaj, E.W., and V.M. Dixit. 2012. Regulation of NF-κB by deubiquitinases. Immunol. Rev. 246:107-124. http://dx.doi.org/10.1111/j.1600-065X.2012.01100.x
19. Hemmi, H., O. Takeuchi, T. Kawai, T. Kaisho, S. Sato, H. Sanjo, M. Matsumoto, K. Hoshino, H. Wagner, K. Takeda, and S. Akira. 2000. A Toll-like receptor recognizes bacterial DNA. Nature. 408:740-745. http://dx.doi.org/10.1038/35047123
20. Iqbal, J., V.T. Neppalli, G. Wright, B.J. Dave, D.E. Horsman, A. Rosenwald, J. Lynch, C.P. Hans, D.D. Weisenburger, T.C. Greiner, et al. 2006. BCL2 expression is a prognostic marker for the activated B-cell-like type of diffuse large B-cell lymphoma. J. Clin. Oncol. 24:961-968. http://dx.doi.org/10.1200/JCO.2005.03.4264
21. Jeelall, Y.S., J.Q. Wang, H.D. Law, H. Domaschenz, H.K. Fung, A. Kallies, S.L. Nutt, C.C. Goodnow, and K. Horikawa. 2012. Human lymphoma mutations reveal CARD11 as the switch between self-antigen-induced B cell death or proliferation and autoantibody production. J. Exp. Med. 209:1907-1917. http://dx.doi.org/10.1084/jem.20112744
22. Kim, Y.M., M.M. Brinkmann, M.E. Paquet, and H.L. Ploegh. 2008. UNC93B1 delivers nucleotide-sensing toll-like receptors to endolysosomes. Nature. 452:234-238. http://dx.doi.org/10.1038/nature06726
23. Krieg, A.M. 2002. CpG motifs in bacterial DNA and their immune effects. Annu. Rev. Immunol. 20:709-760. http://dx.doi.org/10.1146/annurev.immunol.20.100301.064842
24. Leadbetter, E.A., I.R. Rifkin, A.M. Hohlbaum, B.C. Beaudette, M.J. Shlomchik, and A. Marshak-Rothstein. 2002. Chromatin-IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors. Nature. 416:603-607. http://dx.doi.org/10.1038/416603a
25. Lenz, G., R.E. Davis, V.N. Ngo, L. Lam, T.C. George, G.W. Wright, S.S. Dave, H. Zhao, W. Xu, A. Rosenwald, et al. 2008. Oncogenic CARD11 mutations in human diffuse large B cell lymphoma. Science. 319:1676-1679. http://dx.doi.org/10.1126/science.1153629
26. Mercurio, F., H. Zhu, B.W. Murray, A. Shevchenko, B.L. Bennett, J. Li, D.B. Young, M. Barbosa, M. Mann, A. Manning, and A. Rao. 1997. IKK-1 and IKK-2: cytokine-activated IkappaB kinases essential for NF-kappaB activation. Science. 278:860-866. http://dx.doi.org/10.1126/science.278.5339.860
27. Morin, R.D., M. Mendez-Lago, A.J. Mungall, R. Goya, K.L. Mungall, R.D. Corbett, N.A. Johnson, T.M. Severson, R. Chiu, M. Field, et al. 2011. Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma. Nature. 476:298-303. http://dx.doi.org/10.1038/nature10351
28. Ngo, V.N., R.M. Young, R. Schmitz, S. Jhavar, W. Xiao, K.H. Lim, H. Kohlhammer, W. Xu, Y. Yang, H. Zhao, et al. 2011. Oncogenically active MYD88 mutations in human lymphoma. Nature. 470:115-119. http://dx.doi.org/10.1038/nature09671
29. Pasqualucci, L., V. Trifonov, G. Fabbri, J. Ma, D. Rossi, A. Chiarenza, V.A. Wells, A. Grunn, M. Messina, O. Elliot, et al. 2011. Analysis of the coding genome of diffuse large B-cell lymphoma. Nat. Genet. 43:830-837. http://dx.doi.org/10.1038/ng.892
30. Pisitkun, P., J.A. Deane, M.J. Difilippantonio, T. Tarasenko, A.B. Satterthwaite, and S. Bolland. 2006. Autoreactive B cell responses to RNA-related antigens due to TLR7 gene duplication. Science. 312:1669-1672. http://dx.doi.org/10.1126/science.1124978
31. Plenge, R.M., C. Cotsapas, L. Davies, A.L. Price, P.I. de Bakker, J. Maller, I. Pe'er, N.P. Burtt, B. Blumenstiel, M. DeFelice, et al. 2007. Two independent alleles at 6q23 associated with risk of rheumatoid arthritis. Nat. Genet. 39:1477-1482. http://dx.doi.org/10.1038/ng.2007.27
32. Powers, J.P., S. Li, J.C. Jaen, J. Liu, N.P. Walker, Z. Wang, and H. Wesche. 2006. Discovery and initial SAR of inhibitors of interleukin-1 receptor-associated kinase-4. Bioorg. Med. Chem. Lett. 16:2842-2845. http://dx.doi.org/10.1016/j.bmcl.2006.03.020
33. Puente, X.S., M. Pinyol, V. Quesada, L. Conde, G.R. Ordóñez, N. Villamor, G. Escaramis, P. Jares, S. Beà, M. González-Díaz, et al. 2011. Wholegenome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia. Nature. 475:101-105. http://dx.doi.org/10.1038/nature10113
34. Rebeaud, F., S. Hailfinger, A. Posevitz-Fejfar, M. Tapernoux, R. Moser, D. Rueda, O. Gaide, M. Guzzardi, E.M. Iancu, N. Rufer, et al. 2008. The proteolytic activity of the paracaspase MALT1 is key in T cell activation. Nat. Immunol. 9:272-281. http://dx.doi.org/10.1038/ni1568
35. Rossi, D., S. Deaglio, D. Dominguez-Sola, S. Rasi, T. Vaisitti, C. Agostinelli, V. Spina, A. Bruscaggin, S. Monti, M. Cerri, et al. 2011. Alteration of BIRC3 and multiple other NF-κB pathway genes in splenic marginal zone lymphoma. Blood. 118:4930-4934. http://dx.doi.org/10.1182/blood-2011-06-359166
36. Rui, L., R. Schmitz, M. Ceribelli, and L.M. Staudt. 2011. Malignant pirates of the immune system. Nat. Immunol. 12:933-940. http://dx.doi.org/10.1038/ni.2094
37. Schüler, F., L. Dölken, C. Hirt, T. Kiefer, T. Berg, G. Fusch, K. Weitmann, W. Hoffmann, C. Fusch, S. Janz, et al. 2009. Prevalence and frequency of circulating t(14;18)-MBR translocation carrying cells in healthy individuals. Int. J. Cancer. 124:958-963. http://dx.doi.org/10.1002/ijc.23958
38. Shaffer, A.L., A. Rosenwald, and L.M. Staudt. 2002. Lymphoid malignancies: the dark side of B-cell differentiation. Nat. Rev. Immunol. 2:920- 932. http://dx.doi.org/10.1038/nri953
39. Shen, Y., J. Iqbal, J.Z. Huang, G. Zhou, and W.C. Chan. 2004. BCL2 protein expression parallels its mRNA level in normal and malignant B cells. Blood. 104:2936-2939. http://dx.doi.org/10.1182/blood-2004-01-0243
40. Subramanian, S., K. Tus, Q.Z. Li, A. Wang, X.H. Tian, J. Zhou, C. Liang, G. Bartov, L.D. McDaniel, X.J. Zhou, et al. 2006. A Tlr7 translocation accelerates systemic autoimmunity in murine lupus. Proc. Natl. Acad. Sci. USA. 103:9970-9975. http://dx.doi.org/10.1073/pnas.0603912103
41. Tabeta, K., K. Hoebe, E.M. Janssen, X. Du, P. Georgel, K. Crozat, S. Mudd, N. Mann, S. Sovath, J. Goode, et al. 2006. The Unc93b1 mutation 3d disrupts exogenous antigen presentation and signaling via Toll-like receptors 3, 7 and 9. Nat. Immunol. 7:156-164. http://dx.doi.org/10.1038/ni1297
42. Thomson, W., A. Barton, X. Ke, S. Eyre, A. Hinks, J. Bowes, R. Donn, D. Symmons, S. Hider, I.N. Bruce, et al; Wellcome Trust Case Control Consortium; YEAR Consortium. 2007. Rheumatoid arthritis association at 6q23. Nat. Genet. 39:1431-1433. http://dx.doi.org/10.1038/ng.2007.32
43. Tokunaga, F., H. Nishimasu, R. Ishitani, E. Goto, T. Noguchi, K. Mio, K. Kamei, A. Ma, K. Iwai, and O. Nureki. 2012. Specific recognition of linear polyubiquitin by A20 zinc finger 7 is involved in NF-κB regulation. EMBO J. 31:3856-3870. http://dx.doi.org/10.1038/emboj.2012.241
44. Treon, S.P., L. Xu, G. Yang, Y. Zhou, X. Liu, Y. Cao, P. Sheehy, R.J. Manning, C.J. Patterson, C. Tripsas, et al. 2012. MYD88 L265P somatic mutation in Waldenström's macroglobulinemia. N. Engl. J. Med. 367:826-833. http://dx.doi.org/10.1056/NEJMoa1200710
45. Trøen, G., A. Warsame, and J. Delabie. 2013. CD79B and MYD88 Mutations in Splenic Marginal Zone Lymphoma. ISRN Oncol. 2013:252318.
46. Tsujimoto, Y., J. Cossman, E. Jaffe, and C.M. Croce. 1985. Involvement of the bcl-2 gene in human follicular lymphoma. Science. 228:1440-1443. http://dx.doi.org/10.1126/science.3874430
47. Vaux, D.L., S. Cory, and J.M. Adams. 1988. Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre- B cells. Nature. 335:440-442. http://dx.doi.org/10.1038/335440a0
48. Verhelst, K., I. Carpentier, M. Kreike, L. Meloni, L. Verstrepen, T. Kensche, I. Dikic, and R. Beyaert. 2012. A20 inhibits LUBAC-mediated NF-κB activation by binding linear polyubiquitin chains via its zinc finger 7. EMBO J. 31:3845-3855. http://dx.doi.org/10.1038/emboj.2012.240
49. Wang, L., M.S. Lawrence, Y. Wan, P. Stojanov, C. Sougnez, K. Stevenson, L. Werner, A. Sivachenko, D.S. DeLuca, L. Zhang, et al. 2011. SF3B1 and other novel cancer genes in chronic lymphocytic leukemia. N. Engl. J. Med. 365:2497-2506. http://dx.doi.org/10.1056/NEJMoa1109016
50. Woodland, R.T., M.R. Schmidt, and C.B. Thompson. 2006. BLyS and B cell homeostasis. Semin. Immunol. 18:318-326. http://dx.doi.org/10.1016/j.smim.2006.06.001
51. Wotherspoon, A.C., C. Doglioni, T.C. Diss, L. Pan, A. Moschini, M. de Boni, and P.G. Isaacson. 1993. Regression of primary low-grade B-cell gastric lymphoma of mucosa-associated lymphoid tissue type after eradication of Helicobacter pylori. Lancet. 342:575-577. http://dx.doi.org/10.1016/0140-6736(93)91409-F
52. Xu, L., Z.R. Hunter, G. Yang, Y. Zhou, Y. Cao, X. Liu, E. Morra, A. Trojani, A. Greco, L. Arcaini, et al. 2013. MYD88 L265P in Waldenström macroglobulinemia, immunoglobulin M monoclonal gammopathy, and other B-cell lymphoproliferative disorders using conventional and quantitative allele-specific polymerase chain reaction. Blood. 121:2051-2058. http://dx.doi.org/10.1182/blood-2012-09-454355